Trial · NCT06920511
Registered outcomes19
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 19 of 19
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | System Usability Scale (SUS) - Patient Reported Outcome | Week 4 (post-treatment, T1) | Assessment of system usability using the 10-item SUS scale. Scores range from 0 to 100; higher scores indicate better usability. |
| Primary | eHealth Usability Benchmarking Instrument (HUBBI) | Week 4 (post-treatment, T1) | Assessment of system usability using the HUBBI questionnaire. Items rated on a 7-point scale; higher scores indicate better usability. |
| Primary | User Experience Questionnaire - Short Version (UEQ-S) | Week 4 (post-treatment, T1) | Evaluation of pragmatic and hedonic user experience with the UEQ-S. Each item rated from -3 to +3; higher scores indicate more positive experience. |
| Primary | Technology Acceptance Model (TAM) and UTAUT Scores | Week 4 (post-treatment, T1) | Evaluation of perceived usefulness and ease of use via TAM and UTAUT scales. Items rated on 5-point Likert scales. |
| Primary | NASA Task Load Index (NASA-TLX) | Week 4 (post-treatment, T1) | Evaluation of cognitive workload using the NASA-TLX scale. Scores range from 0 to 100; higher scores indicate higher workload. |
| Secondary | Session Attendance and Treatment Adherence | Weeks 1-4 | Evaluation of the acceptance of the PRoBio platform by patients and clinicians, based on session attendance, treatment adherence, and system usability for operators. Additionally, the ability of PRoBio to collect biomechanical and psychophysiological data during treatment will be assessed. These include response accuracy and reaction times (collected by VRRS), movement amplitude and velocity (via RGB-D camera), and physiological indicators (heart rate, respiratory rate, and skin conductance) recorded through wearable sensors. These data will be used offline to customize the rehabilitation sessions. |
| Secondary | Response Accuracy in Cognitive Tasks (VRRS Software) | Weeks 1-4 | Accuracy rate in exercises performed during each session, as recorded by VRRS. |
| Secondary | Reaction Times in Cognitive Tasks (VRRS Software) | Weeks 1-4 | Mean reaction times (ms) recorded during cognitive tasks using the PRoBio platform. |
| Secondary | Movement Amplitude (RGB-D Camera Analysis) | Weeks 1-4 | Mean amplitude of upper limb movements captured via RGB-D camera. |
| Secondary | Movement Velocity (RGB-D Camera Analysis) | Weeks 1-4 | Mean velocity of arm movements during tasks, as measured by RGB-D camera. |
| Secondary | Heart Rate During Sessions (Wearable Sensors) | Weeks 1-4 | Average heart rate recorded during rehabilitation sessions. |
| Secondary | Respiratory Rate During Sessions (Wearable Sensors) | Weeks 1-4 | Average respiratory rate recorded during sessions. |
| Secondary | Skin Conductance Level (SCL) During Sessions | Weeks 1-4 | Average SCL value measured by wearable sensors as indicator of emotional arousal. |
| Other | Cognitive Function - Parkinson's Disease Cognitive Rating Scale (PD-CRS) | Baseline (T0) and Week 4 (T1) | PD-CRS scores will be collected to evaluate changes in cognitive performance. Scores range from 0 to 134; higher scores indicate better cognition. |
| Other | Executive Function - Stroop Color Word Test (SCWT) | Baseline (T0) and Week 4 (T1) | Performance on SCWT will be measured by response times and error rate. |
| Other | Cognitive Flexibility - Trail Making Test (TMT A & B) | Baseline (T0) and Week 4 (T1) | Completion time (in seconds) for TMT-A and TMT-B will be recorded. |
| Other | Quality of Life - Parkinson's Disease Questionnaire (PDQ-39) | Baseline (T0) and Week 4 (T1) | Quality of life will be measured through the PDQ-39. Scores range from 0 to 100; lower scores indicate better quality of life. |
| Other | Mood - Geriatric Depression Scale (GDS-15) | Baseline (T0) and Week 4 (T1) | Scores range from 0 to 15; higher scores indicate more depressive symptoms. |
| Other | Anxiety - Geriatric Anxiety Inventory (GAI) | Baseline (T0) and Week 4 (T1) | Scores range from 0 to 20; higher scores indicate greater anxiety. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06920511/registered